Invention Grant
- Patent Title: CCR2 antagonist peptides
- Patent Title (中): CCR2拮抗剂肽
-
Application No.: US14129758Application Date: 2012-06-26
-
Publication No.: US09434766B2Publication Date: 2016-09-06
- Inventor: Christophe Combadiere , Florian Sennlaub , Constance Auvynet , Sylvian Chemtob , Christiane Quiniou
- Applicant: Christophe Combadiere , Florian Sennlaub , Constance Auvynet , Sylvian Chemtob , Christiane Quiniou
- Applicant Address: FR Paris
- Assignee: Universite Pierre Et Marie Curie (Paris 6)
- Current Assignee: Universite Pierre Et Marie Curie (Paris 6)
- Current Assignee Address: FR Paris
- Agency: Fox Rothschild LLP
- Agent Jianming Jimmy Hao
- Priority: EP11305816 20110627
- International Application: PCT/EP2012/062379 WO 20120626
- International Announcement: WO2013/000922 WO 20130103
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C07K7/08 ; C07K14/715 ; A61K38/00
Abstract:
The invention relates to a peptide comprising the following amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), useful as a CCR2 non-competitive antagonist peptide.
Public/Granted literature
- US20150011477A1 CCR2 ANTAGONIST PEPTIDES Public/Granted day:2015-01-08
Information query
